Both in Pharmaceuticals
Standard BioTools vs Vanda Pharmaceuticals
Over the past year LAB returned −50.7% and VNDA returned −16.1%; their daily moves had a correlation of 0.07.
LAB −50.7% VNDA −16.1%Growth of $1, one year, split-adjusted
| Metric | LAB | VNDA |
|---|---|---|
| Price | $0.6108 | $3.75 |
| Market cap | $241.1M | $226.8M |
| Today | +0.15% | −3.35% |
| 1 month | −19.9% | −18.1% |
| 6 months | −37.6% | −49.3% |
| Year to date | −52.3% | −57.5% |
| 1 year | −49.1% | −13.8% |
| Revenue growth (YoY) | −7.6% | +24.1% |
| Gross margin | 52.4% | 94.1% |
| Net margin | −133.1% | −32.3% |
| P/E (TTM) | 2.8× | — |
| Price / sales | 2.8× | 1.0× |
| Net cash | $476.4M | $138.1M |
| Dividend yield | — | — |
| Volatility (60d) | 45.5% | 39.0% |
| Short % of float | 1.1% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).